Markus Heinonen

Markus Heinonen

Auto-generated profile, based on publicly available information

Markus Heinonen

Aalto University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
EJEmmi Jokinen
Emmi Jokinen
JHJani Huuhtanen
Jani Huuhtanen
SMSatu Mustjoki
Satu Mustjoki
MHMarkus Heinonen
Markus Heinonen
HLHarri Lähdesmäki
Harri Lähdesmäki
Adaptive immune system uses T cell receptors (TCRs) to recognize pathogens and to consequently initiate immune responses. TCRs can be sequenced from individuals and methods analyzing the specificity of the TCRs can help us better understand individuals’ immune status in different disorders. For this task, we have developed TCRGP, a novel Gaussian process method that predicts if TCRs recognize specified epitopes. TCRGP can utilize the amino acid sequences of the complementarity determining regions (CDRs) from TCRα and TCRβ chains and learn which CDRs are important in recognizing different epitopes. Our comprehensive evaluation with epitope-specific TCR sequencing data shows that TCRGP achieves on average higher prediction accuracy in terms of AUROC score than existing state-of-the-art methods in epitope-specificity predictions. We also propose a novel analysis approach for combined single-cell RNA and TCRαβ (scRNA+TCRαβ) sequencing data by quantifying epitope-specific TCRs with TCRGP and identify HBV-epitope specific T cells and their transcriptomic states in hepatocellular carcinoma patients.

26 February 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
SLSofie Lundgren
Sofie Lundgren
JHJani Huuhtanen
Jani Huuhtanen
MKMikko Keränen
Mikko Keränen
XFXingmin Feng
Xingmin Feng
BPBhavisha A. Patel
Bhavisha A. Patel
SMSatu Mustjoki
Satu Mustjoki
Immune aplastic anemia (AA) is a life-threatening bone marrow failure disorder driven by an autoimmune T cell attack against hematopoietic stem and progenitor cells (HSPCs). However, the exact autoantigen targets and role of other immune cells in the pathogenesis of AA are unknown. Here, we analyzed a cohort of 218 patients with AA using single-cell RNA and T cell receptor (TCR) αβ sequencing, TCRβ sequencing, flow cytometry, and plasma cytokine profiling. We identified natural killer (NK) cells and CD8 + terminally differentiated effector T (T EMRA ) cells expressing NK receptors with AA-associated TCRβ motifs as the most dysregulated immune cell populations in AA bone marrow. Functional coculture experiments using primary HSPCs and immune cells showed that NK cells cannot kill HSPCs alone but may sensitize HSPCs to CD8 + T cell–mediated killing through production of interferons. Furthermore, HSPCs induced activation of T cell clones with CD8 + T EMRA NK-like phenotype in coculture. Our results reveal a convergent phenotype of innate and adaptive immune cells that may drive AA.

29 November 2018 in Blood
Verified
Journal Article
Open access
SLSofie Lundgren
Sofie Lundgren
JHJani Huuhtanen
Jani Huuhtanen
MKMikko A Keränen
Mikko A Keränen
CHCassandra M. Hirsch
Cassandra M. Hirsch
EJEmmi Jokinen
Emmi Jokinen
SMSatu Mustjoki
Satu Mustjoki
Background. Acquired aplastic anemia (AA) is a bone marrow failure syndrome, in which patients' hematopoietic stem cells are destroyed, resulting in pancytopenia. The exact mechanism and biological process leading to AA remain largely unknown. Bone marrow destruction is perceived as an immune-mediated process, which is supported by elevated cytotoxic T lymphocyte (CTL) counts, responsiveness to immunosuppressive therapy and skewed CTL T cell receptor (TCR) repertoire. Although there is a well-established role of T cells in the pathology of AA, the putative antigen behind the autoimmune response, and thus, the TCRs recognising the antigen are still unrevealed. Methods. Our cohort comprised of 130 samples, consisting of bone marrow and/or peripheral blood samples from AA patients (n=52) from diagnosis and/or follow-up phases and from healthy controls (n=27). We performed TCRβ sequencing (immunoSEQ, Adaptive Biotechnologies) on sorted AA and healthy CTLs (n=25 and n=27) or AA mononuclear cells (MNCs, n=27). To gain in-depth understanding of the TCR-repertoire, we built two novel analysis methods: 1) an unsupervised clustering method to characterize epitope-specific T cells based on the amino acid -level similarities of TCRs and 2) a probability based classifier to identify AA based on TCR data in the CTL (discovery) and MNC (validation) cohorts. Results. To fully appreciate the complex nature of AA pathology, we divided the cytotoxic T cell response in two distinct categories, private and public response. Private response comprises T cell clones found only in individual patients, and this compartment could explain the variation in treatment responses and disease severity across patients. In the CTL TCR repertoire, we identified patient exclusive expanded T cell clones (>1% frequency in TCR repertoire, n = 317) and treatment responding clones (n = 364). Clustering analysis revealed that there is significant amino acid -level similarity between the TCRs of the private clones. We found several epitope-specific TCR clusters that were associated with different treatment responses, disease severities and HLA-DR15 risk-allele positivity. Interestingly, we discovered that the public response (CTL clones that are statistically enriched in AA patients compared to healthy controls) could discriminate AA from healthy TCR repertoire. Based on these publicly enriched TCRs, we built a classifier which could identify AA CTL TCR repertoire from healthy controls with 97% accuracy (F-score, revieved from leave-one-out cross-validation). We tested our classifier with the validation cohort. The accuracy to diagnose AA based on the TCR repertoire data in the MNC cohort was 0.72. Furthermore, the public clones that differentiated best the AA cases from healthy controls showed statistically significant peptide similarity. These public TCRs occurred also in healthy controls, but with smaller frequencies. When combining the private and public response TCRs, we discovered that some of AA patients' most expanded and treatment responding clones clustered in the same putative epitope-specific clusters with the public TCRs, showing an interesting intersection between public and private signatures. In addition, the comparison of the interesting private and public TCRs against databases of TCR sequences of known antigen specificities hinted that some of these clones may originally target known viral species (CMV, EBV and Influenza A), suggesting a role of these common pathogens in the development of AA. Discussion. CTLTCR repertoire analysis of AA patients revealed a TCR signature that was typical of AA patients, but varied between different patients, and it was validated with an independent dataset. Thus, we could design a TCR-based framework which could identify AA patients based on their TCR repertoire, independently of sample type. A future application for our classifier could be distinguishing AA from other AA-like diseases, like hypoplastic myelodysplastic syndrome. Furthermore, we found groups of TCRs that look similar on amino acid level, and hence these clones may target the same epitope. These TCR clusters were associated with clinical features. Amino acid similarity -based TCR signatures or TCR classifiers have not previously been published for AA or any other autoimmune diseases, and thus our pioneering tools could be utilized to study pathogenesis of other T cell mediated diseases as well.

24 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
EJEmmi Jokinen
Emmi Jokinen
ADAlexandru Dumitrescu
Alexandru Dumitrescu
JHJani Huuhtanen
Jani Huuhtanen
VGVladimir Gligorijević
Vladimir Gligorijević
SMSatu Mustjoki
Satu Mustjoki
HLHarri Lähdesmäki
Harri Lähdesmäki
We introduce TCRconv, a deep learning model for predicting recognition between T-cell receptors and epitopes. TCRconv uses a deep protein language model and convolutions to extract contextualized motifs and provides state-of-the-art TCR-epitope prediction accuracy. Using TCR repertoires from COVID-19 patients, we demonstrate that TCRconv can provide insight into T-cell dynamics and phenotypes during the disease.

23 May 2025 in Machine Learning: Science and Technology
Verified
Journal Article
Open access
PDF file
AJAnirudh Jain
Anirudh Jain
MHMarkus Heinonen
Markus Heinonen
HKHeikki Käsnänen
Heikki Käsnänen
JSJulius Sipilä
Julius Sipilä
SKSamuel Kaski
Samuel Kaski
Multi-target property prediction has the potential to improve generalization by exploiting the positive transfer between targets. Molecular generative models utilize independent single-target property prediction networks to discover novel molecules. We propose using multi-target networks to jointly predict several molecular properties and learn better representations by exploiting auxiliary information. Our multi-target model shows improvement in prediction accuracy on the test set. We additionally present results demonstrating promising performance in property prediction in these generative models does not translate to optimization. More specifically, random exploration is competitive with gradient-based strategies and better methods are needed.

9 June 2022 in arXiv
Verified
Preprint
Open access
PDF file
TTTrung Trinh
Trung Trinh
MHMarkus Heinonen
Markus Heinonen
LALuigi Acerbi
Luigi Acerbi
SKSamuel Kaski
Samuel Kaski
Bayesian neural networks (BNNs) promise improved generalization under covariate shift by providing principled probabilistic representations of epistemic uncertainty. However, weight-based BNNs often struggle with high computational complexity of large-scale architectures and datasets. Node-based BNNs have recently been introduced as scalable alternatives, which induce epistemic uncertainty by multiplying each hidden node with latent random variables, while learning a point-estimate of the weights. In this paper, we interpret these latent noise variables as implicit representations of simple and domain-agnostic data perturbations during training, producing BNNs that perform well under covariate shift due to input corruptions. We observe that the diversity of the implicit corruptions depends on the entropy of the latent variables, and propose a straightforward approach to increase the entropy of these variables during training. We evaluate the method on out-of-distribution image classification benchmarks, and show improved uncertainty estimation of node-based BNNs under covariate shift due to input perturbations. As a side effect, the method also provides robustness against noisy training labels.